Cold virus turned cancer killer enters human trials
Disease control
Recruiting now
This early-phase trial tests ATTR-01, a modified cold virus designed to infect and multiply only in cancer cells, delivering an immune-boosting drug directly into the tumor. The study involves 72 adults with solid tumors who have not responded to standard treatments. The goal is …
Phase: PHASE1, PHASE2 • Sponsor: Accession Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC